我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
100.0%
暂无批准数据
- Missouri allocates $5 million from its opioid settlement fund to research psilocybin's potential in treating opioid use disorders and reducing overdose deaths. - The Department of Mental Health seeks expert input to develop competitive grants for psilocybin-related opioid research projects. - The initiative follows HB 2010, initially considering ibogaine but later focusing on psilocybin for opioid addiction treatment research. - Researchers are invited to provide feedback on how psilocybin research would be conducted, its duration, and its alignment with national opioid settlement guidelines.
